Skip to Main content Skip to Navigation
Journal articles

Resveratrol metabolites are able to reduce steatosis in cultured hepatocytes

Abstract : Steatosis is characterized primarily by excessive lipid accumulation in the form of triglycerides in the liver. Although resveratrol shows a low bioavailability, it has significant positive effects on steatosis. The aim of this study was to analyze whether some phase II and microbial resveratrol metabolites (trans-resveratrol-4-O-glucuronide (R-4G); trans-resveratrol-3-O-glucuronide (R-3G); trans-resveratrol-3-O-sulfate (R-S) and dihydro-resveratrol (DH-R) were effective in reducing hepatocyte fat accumulation. An in vitro model mimicking the hepatocyte situation in fatty liver was developed by incubating mouse AML12 hepatocytes with palmitic acid (PA). For cell treatments, hepatocytes were incubated with 1, 10, or 25 µM resveratrol or its metabolites. Triglycerides and cell viability were assessed using commercial kits. Protein expression of enzymes and transporters involved in triglyceride metabolism were analyzed by western blot. We show for the first time that resveratrol and all the tested metabolites, at 1 µM, partially prevented lipid accumulation induced by the saturated fatty acid PA in AML12 hepatocytes. This effect was mainly due to the inhibition of de novo lipogenesis. This demonstrates that the low bioavailability of resveratrol is not as big a problem as it was thought to be, because resveratrol metabolites contribute to the delipidating effects of the parent compound.
Document type :
Journal articles
Complete list of metadata

https://hal.inrae.fr/hal-03176091
Contributor : Marion Desailly <>
Submitted on : Monday, March 22, 2021 - 10:28:29 AM
Last modification on : Monday, March 22, 2021 - 10:29:08 AM

File

2020_Trepiana_pharmaceutilcals...
Publisher files allowed on an open archive

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Collections

Citation

Jenifer Trepiana, Stéphanie Krisa, Elodie Renouf, Maria Portillo. Resveratrol metabolites are able to reduce steatosis in cultured hepatocytes. Pharmaceuticals, MDPI, 2020, 13 (10), pp.1-17. ⟨10.3390/ph13100285⟩. ⟨hal-03176091⟩

Share

Metrics

Record views

36

Files downloads

16